Europe & Central Asia (IDA & IBRD countries) vs Latvia: Immunization, HepB3
Immunization, HepB3 over time
- Europe & Central Asia (IDA & IBRD countries)
- Latvia
How they compare
Latvia currently reports 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries), a difference of 6.3%.
That makes Latvia's figure about 1.1 times Europe & Central Asia (IDA & IBRD countries)'s.
The two have swapped places 3 times across 28 shared years of data; in 1997 it was Europe & Central Asia (IDA & IBRD countries) ahead.
Europe & Central Asia (IDA & IBRD countries) ranks 4th and Latvia ranks 1st of 47 groups.
Latvia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Europe & Central Asia (IDA & IBRD countries) | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 16.1% | 36.3% | 20.2% | Latvia |
| 2000s | 79.9% | 95.4% | 15.5% | Latvia |
| 2010s | 92.0% | 94.1% | 2.1% | Latvia |
| 2020s | 93.3% | 96.8% | 3.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Europe & Central Asia (IDA & IBRD countries) or Latvia?
- Latvia, at 99.0% against 92.7% in Europe & Central Asia (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hepb3 between Europe & Central Asia (IDA & IBRD countries) and Latvia?
- 6.3%, with Latvia ahead.
- How many years of comparable data are there for Europe & Central Asia (IDA & IBRD countries) and Latvia?
- 28 years are reported by both, from 1997 to 2024.
- How do Europe & Central Asia (IDA & IBRD countries) and Latvia rank globally for immunization, hepb3?
- Europe & Central Asia (IDA & IBRD countries) ranks 4th and Latvia ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.